Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

INDUCIBILITY OF CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS BY INTERFERON-GAMMA IS ASSOCIATED WITH REDUCED TUMORIGENICITY IN C3H MOUSE FIBROBLASTS TRANSFORMED BY V-KI-RAS

Tools
- Tools
+ Tools

UNSPECIFIED (1991) INDUCIBILITY OF CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS BY INTERFERON-GAMMA IS ASSOCIATED WITH REDUCED TUMORIGENICITY IN C3H MOUSE FIBROBLASTS TRANSFORMED BY V-KI-RAS. JOURNAL OF EXPERIMENTAL MEDICINE, 173 (1). pp. 193-196. ISSN 0022-1007

Full text not available from this repository.

Abstract

Paired lines of C3H mouse fibroblasts transformed with murine sarcoma virus (Kirsten strain) were prepared that express high or low levels of class II major histocompatibility complex antigen after treatment with interferon-gamma (IFN-gamma). Here, we described a comparison of the tumorigenicity of these lines in euthymic syngeneic and thymus-deficient mu/mu mice and in mice depleted of IFN-gamma. The class II-inducible cells are clearly less tumorigenic than the noninducible cells in syngeneic mice, but of similar tumorigenicity in mu/mu mice and in mice treated with antibodies to deplete IFN-gamma. We propose that in this system, IFN-gamma induction of class II antigens on the tumor cell surface operates to limit tumor growth; ras expression, which inhibits induction of class II antigens, prevents this and so allows tumor growth.

Item Type: Journal Article
Subjects: Q Science > QR Microbiology > QR180 Immunology
R Medicine
Journal or Publication Title: JOURNAL OF EXPERIMENTAL MEDICINE
Publisher: ROCKEFELLER UNIV PRESS
ISSN: 0022-1007
Date: 1 January 1991
Volume: 173
Number: 1
Number of Pages: 4
Page Range: pp. 193-196
Publication Status: Published
URI: http://wrap.warwick.ac.uk/id/eprint/22932

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us